SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053578
Filing Date
2020-11-12
Accepted
2020-11-12 16:17:13
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-10q_20200930.htm 10-Q 2778209
2 EX-31.1 pstx-ex311_9.htm EX-31.1 17239
3 EX-31.2 pstx-ex312_8.htm EX-31.2 17215
4 EX-32.1 pstx-ex321_6.htm EX-32.1 7836
5 EX-32.2 pstx-ex322_7.htm EX-32.2 7825
6 GRAPHIC grug3sn3342s000001.jpg GRAPHIC 28107
  Complete submission text file 0001564590-20-053578.txt   8433892

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pstx-20200930.xml EX-101.INS 1533566
8 XBRL TAXONOMY EXTENSION SCHEMA pstx-20200930.xsd EX-101.SCH 52621
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstx-20200930_cal.xml EX-101.CAL 54493
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstx-20200930_def.xml EX-101.DEF 216162
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20200930_lab.xml EX-101.LAB 468624
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20200930_pre.xml EX-101.PRE 358860
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 201306931
SIC: 2836 Biological Products, (No Diagnostic Substances)